Cases in Acute Kidney Injury: Applications for Clinical Practice
Host: Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
Guest: Peter Pickkers, MD, PhD
Guest: Alexander Zarbock, MD
Acute kidney injury (AKI) is a complication in 10%-15% of patients admitted to the hospital and is even more prevalent in patients in the ICU where the incidence can exceed 50%. Serum creatinine and urine output are traditionally used to define AKI, but these markers are of limited value since they only appear following kidney injury. Early identification of patients at high risk for developing AKI is at the heart of improving AKI outcomes. This task is now clinically feasible with the emergence of predictive biomarkers of kidney stress.
Join us for this case-based panel discussion highlighting how kidney stress biomarkers can be incorporated into clinical decision-making for patients at high risk for developing AKI.